JPS6139947B2 - - Google Patents
Info
- Publication number
- JPS6139947B2 JPS6139947B2 JP52014335A JP1433577A JPS6139947B2 JP S6139947 B2 JPS6139947 B2 JP S6139947B2 JP 52014335 A JP52014335 A JP 52014335A JP 1433577 A JP1433577 A JP 1433577A JP S6139947 B2 JPS6139947 B2 JP S6139947B2
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidine
- dihydro
- oxo
- melting point
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65778776A | 1976-02-13 | 1976-02-13 | |
| US05/748,851 US4082751A (en) | 1976-02-13 | 1976-12-08 | Therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52118481A JPS52118481A (en) | 1977-10-04 |
| JPS6139947B2 true JPS6139947B2 (cs) | 1986-09-06 |
Family
ID=27097492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1433577A Granted JPS52118481A (en) | 1976-02-13 | 1977-02-14 | Therapeutic agents |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS52118481A (cs) |
| AU (1) | AU508970B2 (cs) |
| CA (1) | CA1083152A (cs) |
| CH (1) | CH635339A5 (cs) |
| DE (1) | DE2705609A1 (cs) |
| DK (1) | DK149044C (cs) |
| FI (1) | FI62533C (cs) |
| FR (1) | FR2340943A1 (cs) |
| GB (1) | GB1541351A (cs) |
| IE (1) | IE44603B1 (cs) |
| LU (1) | LU76722A1 (cs) |
| NL (1) | NL173055C (cs) |
| SE (1) | SE433494B (cs) |
| YU (1) | YU41567B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4419357A (en) * | 1982-01-18 | 1983-12-06 | The Dow Chemical Company | 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones |
| CN101747282A (zh) * | 2008-12-10 | 2010-06-23 | 上海特化医药科技有限公司 | 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3883653A (en) * | 1972-10-24 | 1975-05-13 | Pfizer | Method of preventing asthmatic symptoms |
-
1977
- 1977-02-03 AU AU21895/77A patent/AU508970B2/en not_active Expired
- 1977-02-08 LU LU76722A patent/LU76722A1/xx unknown
- 1977-02-09 FR FR7703650A patent/FR2340943A1/fr active Granted
- 1977-02-09 CA CA271,406A patent/CA1083152A/en not_active Expired
- 1977-02-09 GB GB5437/77A patent/GB1541351A/en not_active Expired
- 1977-02-09 FI FI770427A patent/FI62533C/fi not_active IP Right Cessation
- 1977-02-10 DE DE19772705609 patent/DE2705609A1/de active Granted
- 1977-02-10 DK DK57377A patent/DK149044C/da not_active IP Right Cessation
- 1977-02-11 CH CH173477A patent/CH635339A5/de not_active IP Right Cessation
- 1977-02-11 IE IE297/77A patent/IE44603B1/en unknown
- 1977-02-11 SE SE7701552A patent/SE433494B/xx not_active IP Right Cessation
- 1977-02-11 NL NLAANVRAGE7701483,A patent/NL173055C/xx not_active IP Right Cessation
- 1977-02-11 YU YU354/77A patent/YU41567B/xx unknown
- 1977-02-14 JP JP1433577A patent/JPS52118481A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| AU508970B2 (en) | 1980-04-17 |
| GB1541351A (en) | 1979-02-28 |
| DE2705609C2 (cs) | 1988-12-15 |
| NL173055C (nl) | 1983-12-01 |
| FI770427A7 (cs) | 1977-08-14 |
| JPS52118481A (en) | 1977-10-04 |
| FI62533B (fi) | 1982-09-30 |
| FR2340943B1 (cs) | 1981-01-09 |
| CA1083152A (en) | 1980-08-05 |
| IE44603B1 (en) | 1982-01-27 |
| SE433494B (sv) | 1984-05-28 |
| NL7701483A (nl) | 1977-08-16 |
| IE44603L (en) | 1977-08-13 |
| DE2705609A1 (de) | 1977-08-25 |
| DK149044B (da) | 1985-12-30 |
| YU35477A (en) | 1982-10-31 |
| DK149044C (da) | 1986-06-02 |
| FI62533C (fi) | 1983-01-10 |
| FR2340943A1 (fr) | 1977-09-09 |
| NL173055B (nl) | 1983-07-01 |
| LU76722A1 (cs) | 1977-08-18 |
| CH635339A5 (en) | 1983-03-31 |
| AU2189577A (en) | 1978-08-10 |
| DK57377A (da) | 1977-08-14 |
| SE7701552L (sv) | 1977-09-23 |
| YU41567B (en) | 1987-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5118686A (en) | Phenylpyrimidones | |
| CA1098520A (en) | Optionally substituted 3-(1h-tetrazol-5-yl)-4h- pyrido¬1,2-a| pyrimidin-4-ones | |
| US4209623A (en) | Pyrimidine-5-N-(1H-tetrazol-5-yl)-carboxamides | |
| US8183253B2 (en) | Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase | |
| JP2002520395A (ja) | キノリン誘導体 | |
| US20200031844A1 (en) | Tetrahydrothiopyranopyrimidine derivatives as anti-HIV agent | |
| US4082751A (en) | Therapeutic agents | |
| KR900003650B1 (ko) | (1h-테트라졸-5-일)-2(1h)-퀴놀리논, 나프티리디논 및 그의 제조방법 | |
| JPS6222771A (ja) | ５−置換−６−アミノピリミジン誘導体、組成物および使用 | |
| JPS6139947B2 (cs) | ||
| US4031093A (en) | 1,6-Dihydro-6-oxo-2-(ortho-substituted phenyl)pyrimidine-5-carboxylic acid derivatives | |
| JPS60502003A (ja) | 強心剤として有効な〔（ピリジニル）−２−ピリミジニル〕尿素及び同化合物を含む製剤 | |
| KR900003649B1 (ko) | (1H-테트라졸-5-일)테트라졸로[1,5-a]-퀴놀린의 제조방법 | |
| US5290933A (en) | Phenylpyrimidone derivatives | |
| CA1117112A (en) | Pyrido¬1,2-a|pyrimidine-3-n-(1h-tetrazol-5-yl| carboxamide derivatives | |
| JP2930539B2 (ja) | トリフルオロメチルキノリンカルボン酸誘導体 | |
| NZ287550A (en) | 8-trifluoromethylquinolinecarboxylic acid derivatives; medicaments | |
| US3968213A (en) | Method of preventing asthmatic symptoms | |
| US3927214A (en) | Method of preventing asthmatic symptoms | |
| JPH0450310B2 (cs) | ||
| US3957784A (en) | Bis(4-[4'-hydroxy-5'-carboxy-2'-pyrimidinyl]phenoxy)alkanes | |
| JP2514812B2 (ja) | ３−（１Ｈ−テトラゾ−ル−５− イル） チエノ〔２，３−ｄ〕 ピリミジン−４（３Ｈ）−オン類 | |
| US3917835A (en) | A method of preventing asthmatic symptoms | |
| US3927215A (en) | Method of preventing asthmatic symptoms | |
| KR790001315B1 (ko) | N-테트라졸릴-1-옥소-1H-6-(R₃-치환) 피리미도[1,2-a] 퀴놀린-2-카복스아미드류의 제조방법. |